Nothing said here yet.
to join the conversation.
| DEVIVO JOSEPHPresident & CEO | Sell | 35,790 | $358.6K | Tue, Oct 6 |
| Carlson MeganCAO and SVP, Finance | Sell | 10,114 | $88.4K | Fri, Oct 2 |
| DEVIVO JOSEPHPresident & CEO | Sell | 3,169 | $31.8K | Wed, Sep 23 |
| DEVIVO JOSEPHPresident & CEO | Sell | 2,811 | $28.1K | Tue, Sep 22 |
| Cashman SteveChief Business Officer | Sell | 140,112 | $1.0M | Fri, Sep 4 |
| Carlson MeganCAO and SVP, Finance | Sell | 13,804 | $100.8K | Fri, Sep 4 |
| Caezza NicholasDeputy General Counsel | Sell | 1,709 | $13.9K | Wed, Sep 2 |
| ROBBINS LARRYDirector | Sell | 582,500 | $5.2M | Mon, Aug 17 |
| ROBBINS LARRYDirector | Sell | 824,700 | $7.2M | Fri, Aug 14 |
| Phanstiel S. LouiseDirector | Buy | 115,200 | $999.5K | Fri, Aug 14 |
| ROBBINS LARRYDirector | Sell | 500,000 | $4.6M | Thu, Aug 13 |
| ROBBINS LARRYDirector | Sell | 215,233 | $2.1M | Thu, Aug 13 |
Butterfly Network just watched its stock drop 14.9% to US$6.39 in Friday trading, even as the latest Q3 2026 report landed with one of the cleanest stories this medtech has put up in a while.
Butterfly Network (BFLY) moved into focus after third quarter 2026 results showed revenue of US$32.6 million, a lower net loss, and an increase to full year guidance alongside new federal and product milestones.
Revenue jumped 52% YoY to $32.6M, beating guidance with record margins.
Butterfly Network (NYSE:BFLY) reported third-quarter 2026 revenue of $32.6 million, up 52% from a year earlier and 9% above the high end of its guidance range, as growth in its Embedded business and enterprise-focused point-of-care ultrasound operations…
Butterfly Network (BFLY) delivered earnings and revenue surprises of +66.67% and +16.05%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
Butterfly Network and the Edward Via College of Osteopathic Medicine recently agreed a long term alliance that equips every incoming VCOM medical student with a Butterfly iQ3 ultrasound probe and connects training, clinical use and rural community care…